BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 2021;70:784-95. [PMID: 33127832 DOI: 10.1136/gutjnl-2020-322526] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 79.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao X, Sun S, Zi Y, Liu Y, Yang J, Ren L, Chen G, Cao Z, Hou W, Song Y, Shang J, Jiang H, Li Z, Wang H, Zhang P, Shi L, Li QZ, Yu Y, Zheng Y. Comprehensive microRNA-seq transcriptomic profiling across 11 organs, 4 ages, and 2 sexes of Fischer 344 rats. Sci Data 2022;9:201. [PMID: 35551205 DOI: 10.1038/s41597-022-01285-7] [Reference Citation Analysis]
2 Giovannini C, Fornari F, Piscaglia F, Gramantieri L. Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs. Cells 2021;10:521. [PMID: 33804511 DOI: 10.3390/cells10030521] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Li X, Yu H, Gong Y, Wu P, Feng Q, Liu C. Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms. J Ethnopharmacol 2022;284:114801. [PMID: 34748868 DOI: 10.1016/j.jep.2021.114801] [Reference Citation Analysis]
4 Lan H, Yuan J, Zeng D, Liu C, Guo X, Yong J, Zeng X, Xiao S. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer. Front Genet 2021;12:693259. [PMID: 34512721 DOI: 10.3389/fgene.2021.693259] [Reference Citation Analysis]
5 You H, Wang L, Bu F, Meng H, Pan X, Li J, Zhang Y, Wang A, Yin N, Huang C, Li J. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. FASEB J 2021;35:e21700. [PMID: 34105828 DOI: 10.1096/fj.202002319RRR] [Reference Citation Analysis]
6 Tai Y, Zhao C, Gao J, Lan T, Tong H. Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis. PeerJ 2021;9:e11910. [PMID: 34434654 DOI: 10.7717/peerj.11910] [Reference Citation Analysis]
7 Yan X, Kang D, Lin Y, Qi S, Jiang C. CBX4-dependent regulation of HDAC3 nuclear translocation reduces Bmp2-induced osteoblastic differentiation and calcification in adamantinomatous craniopharyngioma. Cell Commun Signal 2022;20:3. [PMID: 34980138 DOI: 10.1186/s12964-021-00797-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ren X, Li A, Ying E, Fang J, Li M, Yu J. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression. Bioengineered 2021;12:1530-42. [PMID: 33934686 DOI: 10.1080/21655979.2021.1918507] [Reference Citation Analysis]
9 Yin Z, Chen C. Biological Functions and Clinical Prospects of Extracellular Non-Coding RNAs in Diabetic Cardiomyopathy: an Updated Review. J Cardiovasc Transl Res 2022. [PMID: 35175553 DOI: 10.1007/s12265-022-10217-0] [Reference Citation Analysis]
10 BinMowyna MN, AlFaris NA, Al-Sanea EA, AlTamimi JZ, Aldayel TS. Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis. Arch Physiol Biochem 2022;:1-16. [PMID: 35254877 DOI: 10.1080/13813455.2022.2046106] [Reference Citation Analysis]
11 Sulaiman SA, Dorairaj V, Abdul Ghafar KN, Abdul Murad NA. Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis. Livers 2021;1:263-85. [DOI: 10.3390/livers1040021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mei R, Qin W, Zheng Y, Wan Z, Liu L. Role of Adipose Tissue Derived Exosomes in Metabolic Disease. Front Endocrinol 2022;13:873865. [DOI: 10.3389/fendo.2022.873865] [Reference Citation Analysis]
13 Qin S, Xu J, Yi Y, Jiang S, Jin P, Xia X, Ma F. Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma. Front Oncol 2021;11:691115. [PMID: 34307154 DOI: 10.3389/fonc.2021.691115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Luo Y, Li H, Huang H, Xue L, Li H, Liu L, Fu H. Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis. Medicine (Baltimore) 2021;100:e26194. [PMID: 34087888 DOI: 10.1097/MD.0000000000026194] [Reference Citation Analysis]
15 Li L, Xiao F, Liu G, Chen Y, Xu Y. Serum Exosomal lncRNA AC007099.1 Regulates the Expression of Neuropeptide-Related FAP, as a Potential Biomarker for Hepatocarcinogenesis. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/9501008] [Reference Citation Analysis]
16 Zhou X, Liang Z, Qin S, Ruan X, Jiang H. Serum-derived miR-574-5p-containing exosomes contribute to liver fibrosis by activating hepatic stellate cells. Mol Biol Rep 2021. [PMID: 34843038 DOI: 10.1007/s11033-021-07008-2] [Reference Citation Analysis]
17 Bruneau A, Hundertmark J, Guillot A, Tacke F. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Front Med (Lausanne) 2021;8:725390. [PMID: 34650994 DOI: 10.3389/fmed.2021.725390] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Yang YL, Tsai MC, Chang YH, Wang CC, Chu PY, Lin HY, Huang YH. MIR29A Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting LOX, LOXL2, and VEGFA. Int J Mol Sci 2021;22:6001. [PMID: 34206143 DOI: 10.3390/ijms22116001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Tarancon-diez L, Consuegra I, Vazquez-alejo E, Ramos-ruiz R, Ramos JT, Navarro ML, Muñoz-fernández MÁ. miRNA Profile Based on ART Delay in Vertically Infected HIV-1 Youths Is Associated With Inflammatory Biomarkers and Activation and Maturation Immune Levels. Front Immunol 2022;13:878630. [DOI: 10.3389/fimmu.2022.878630] [Reference Citation Analysis]
20 Wu Y, Liang Y, Li M, Zhang H. Knockdown of long non-coding RNA SNHG8 suppresses the progression of esophageal cancer by regulating miR-1270/BACH1 axis. Bioengineered 2022;13:3384-94. [DOI: 10.1080/21655979.2021.2021064] [Reference Citation Analysis]
21 Yang CX, Yao DM. Research advances in pathogenesis and diagnostic markers of drug-induced liver injury. Shijie Huaren Xiaohua Zazhi 2021; 29(13): 726-732 [DOI: 10.11569/wcjd.v29.i13.726] [Reference Citation Analysis]
22 Almohawes ZN, El-kott A, Morsy K, Shati AA, El-kenawy AE, Khalifa HS, Elsaid FG, Abd-lateif AM, Abu-zaiton A, Ebealy ER, Abdel-daim MM, Ghanem RA, Abd-ella EM. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats. Archives of Physiology and Biochemistry. [DOI: 10.1080/13813455.2021.2024578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zhang J, Liu Q, He J, Li Y. Novel Therapeutic Targets in Liver Fibrosis. Front Mol Biosci 2021;8:766855. [PMID: 34805276 DOI: 10.3389/fmolb.2021.766855] [Reference Citation Analysis]
24 Zhang W, Liu Z, Xia S, Yao L, Li L, Gan Z, Tang H, Guo Q, Yan X, Sun Z. GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma. Aging (Albany NY) 2021;13:25304-24. [PMID: 34894398 DOI: 10.18632/aging.203748] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Tu W, Gong J, Song J, Tian D, Wang Z. miR-20a/TCF4 axis-mediated inhibition of hepatocytes proliferation impairs liver regeneration in mice PHx model by regulating CDC2 and CDC6. J Cell Mol Med 2021;25:5220-37. [PMID: 33951279 DOI: 10.1111/jcmm.16530] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Xu X, Jiang W, Han P, Zhang J, Tong L, Sun X. MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met. JHC 2022;Volume 9:113-26. [DOI: 10.2147/jhc.s349369] [Reference Citation Analysis]
27 Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N. MicroRNA Therapeutics in Cancer: Current Advances and Challenges. Cancers (Basel) 2021;13:2680. [PMID: 34072348 DOI: 10.3390/cancers13112680] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Kim SM, Song GY, Shim A, Lee JH, Eom CB, Liu C, Yang YM, Seki E. Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4. Exp Mol Med 2022. [PMID: 35662287 DOI: 10.1038/s12276-022-00781-5] [Reference Citation Analysis]
29 Hwang S, Yun H, Moon S, Cho YE, Gao B. Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 2021;12:751802. [PMID: 34707573 DOI: 10.3389/fendo.2021.751802] [Reference Citation Analysis]
30 Li L, Feng T, Zhou W, Liu Y, Li H. miRNAs in decidual NK cells: regulators worthy of attention during pregnancy. Reprod Biol Endocrinol 2021;19:150. [PMID: 34600537 DOI: 10.1186/s12958-021-00812-2] [Reference Citation Analysis]
31 Yang L, Yue W, Zhang H, Zhang Z, Xue R, Dong C, Liu F, Chang N, Yang L, Li L. Dual Targeting of Angipoietin-1 and von Willebrand Factor by microRNA-671-5p Attenuates Liver Angiogenesis and Fibrosis. Hepatol Commun 2022. [PMID: 35014213 DOI: 10.1002/hep4.1888] [Reference Citation Analysis]
32 Wang J, Wang X, Zhang X, Shao T, Luo Y, Wang W, Han Y. Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges. Front Oncol 2022;12:884369. [PMID: 35692794 DOI: 10.3389/fonc.2022.884369] [Reference Citation Analysis]
33 She S, Ren L, Chen P, Wang M, Chen D, Wang Y, Chen H. Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease. Front Immunol 2022;13:812431. [DOI: 10.3389/fimmu.2022.812431] [Reference Citation Analysis]
34 Yu L, Li W, Yang P, Zhang W, Tao H, Ge G, Yang H, Bai J, Wang H, Geng D. Osteoblastic microRNAs in skeletal diseases: Biological functions and therapeutic implications. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.06.002] [Reference Citation Analysis]
35 Fang Z, Dou G, Wang L. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Int J Biol Sci 2021;17:1851-63. [PMID: 33994867 DOI: 10.7150/ijbs.59588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wang L, Wang X, Kong L, Li Y, Huang K, Wu J, Wang C, Sun H, Sun P, Gu J, Luo H, Liu K, Meng Q. Activation of PGC-1α via isoliquiritigenin-induced downregulation of miR-138-5p alleviates nonalcoholic fatty liver disease. Phytother Res 2022. [PMID: 35041255 DOI: 10.1002/ptr.7334] [Reference Citation Analysis]
37 Gu J, Xu H, Chen Y, Li N, Hou X. MiR-223 as a Regulator and Therapeutic Target in Liver Diseases. Front Immunol 2022;13:860661. [PMID: 35371024 DOI: 10.3389/fimmu.2022.860661] [Reference Citation Analysis]
38 Mohr R, Özdirik B, Lambrecht J, Demir M, Eschrich J, Geisler L, Hellberg T, Loosen SH, Luedde T, Tacke F, Hammerich L, Roderburg C. From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis. Int J Mol Sci 2021;22:1492. [PMID: 33540837 DOI: 10.3390/ijms22031492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Fang Q, Chen W, Jian Y, Li Y, Lian W, Wan H, Chen S, Li F, Chen Y, Ali L. Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection. Journal of Healthcare Engineering 2022;2022:1-7. [DOI: 10.1155/2022/8430276] [Reference Citation Analysis]
40 Habash NW, Sehrawat TS, Shah VH, Cao S. Epigenetics of Alcohol-Related Liver Diseases. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100466] [Reference Citation Analysis]
41 Cai C, Lin J, Li J, Wang X, Xu L, Chen D, Chen Y, Khan A. miRNA-432 and SLC38A1 as Predictors of Hepatocellular Carcinoma Complicated with Alcoholic Steatohepatitis. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/4832611] [Reference Citation Analysis]
42 Zhang Q, Zhang Q, Li B, Qu Y, Li Z, Lu L, Li R, Cai X. The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B. Mediators Inflamm 2021;2021:6636947. [PMID: 33727891 DOI: 10.1155/2021/6636947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Liu Y, Zhang Y, Xiao B, Tang N, Hu J, Liang S, Pang Y, Xu H, Ao J, Yang J, Liang X, Wei L, Wang Y, Luo X. MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma. Cell Death Dis 2021;12:618. [PMID: 34131101 DOI: 10.1038/s41419-021-03905-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Li M, Liu Y, Jiang X, Hang Y, Wang H, Liu H, Chen Z, Xiao Y. Inhibition of miR-144-3p exacerbates non-small cell lung cancer progression by targeting CEP55. Acta Biochim Biophys Sin (Shanghai) 2021;53:1398-407. [PMID: 34435195 DOI: 10.1093/abbs/gmab118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Virzì A, Gonzalez-Motos V, Tripon S, Baumert TF, Lupberger J. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. J Clin Med 2021;10:977. [PMID: 33801181 DOI: 10.3390/jcm10050977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Favero A, Segatto I, Perin T, Belletti B. The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response. Wiley Interdiscip Rev RNA 2021;:e1659. [PMID: 33951281 DOI: 10.1002/wrna.1659] [Reference Citation Analysis]
47 Yang M, Zhang CY. Diagnostic biomarkers for pancreatic cancer: An update. World J Gastroenterol 2021; 27(45): 7862-7865 [PMID: 34963749 DOI: 10.3748/wjg.v27.i45.7862] [Reference Citation Analysis]
48 Alshammari GM, Al-Qahtani WH, AlFaris NA, Alzahrani NS, Alkhateeb MA, Yahya MA. Quercetin prevents cadmium chloride-induced hepatic steatosis and fibrosis by downregulating the transcription of miR-21. Biofactors 2021;47:489-505. [PMID: 33733575 DOI: 10.1002/biof.1724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Czaja AJ. Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis. Expert Rev Clin Immunol 2022. [PMID: 35510750 DOI: 10.1080/1744666X.2022.2074839] [Reference Citation Analysis]
50 Shi T, Morishita A, Kobara H, Masaki T. The Role of microRNAs in Cholangiocarcinoma. Int J Mol Sci 2021;22:7627. [PMID: 34299246 DOI: 10.3390/ijms22147627] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Hu O, Li Z, Tong Y, Wang Q, Chen Z. DNA functionalized double quantum dots-based fluorescence biosensor for one-step simultaneous detection of multiple microRNAs. Talanta 2021;235:122763. [PMID: 34517624 DOI: 10.1016/j.talanta.2021.122763] [Reference Citation Analysis]
52 El-Mahdy HA, Sallam AM, Ismail A, Elkhawaga SY, Elrebehy MA, Doghish AS. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathol Res Pract 2022;233:153886. [PMID: 35405621 DOI: 10.1016/j.prp.2022.153886] [Reference Citation Analysis]
53 Wang X, Seo W, Park SH, Fu Y, Hwang S, Rodrigues RM, Feng D, Gao B, He Y. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types. Int J Biol Sci 2021;17:1153-67. [PMID: 33867837 DOI: 10.7150/ijbs.58365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Yu D, Xu Z, Cheng X, Qin J. The role of miRNAs in MDMX-p53 interplay. J Evid Based Med 2021;14:152-60. [PMID: 33988919 DOI: 10.1111/jebm.12428] [Reference Citation Analysis]
55 Zhou S, Xu J, Wang D, Wang Y, Meng L, Cao S. Development an Immune-Related MicroRNA Risk Index in Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5224434] [Reference Citation Analysis]
56 He Y, Rodrigues RM, Wang X, Seo W, Ma J, Hwang S, Fu Y, Trojnár E, Mátyás C, Zhao S, Ren R, Feng D, Pacher P, Kunos G, Gao B. Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis. J Clin Invest 2021;131:141513. [PMID: 33301423 DOI: 10.1172/JCI141513] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
57 Fu B, Liu W, Zhu C, Li P, Wang L, Pan L, Li K, Cai P, Meng M, Wang Y, Zhang A, Tang W, An M. Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a/BRD4 axis. Int J Biol Sci 2021;17:3104-17. [PMID: 34421353 DOI: 10.7150/ijbs.58916] [Reference Citation Analysis]
58 Pécheur EI. Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a 'miR'-velous opportunity of early diagnosis? AIDS 2021;35:1499-500. [PMID: 34185715 DOI: 10.1097/QAD.0000000000002921] [Reference Citation Analysis]
59 Khan AA, Gupta V, Mahapatra NR. Key regulatory miRNAs in lipid homeostasis: implications for cardiometabolic diseases and development of novel therapeutics. Drug Discov Today 2022:S1359-6446(22)00190-8. [PMID: 35550438 DOI: 10.1016/j.drudis.2022.05.003] [Reference Citation Analysis]
60 Cheng R, Xu H, Hong Y. miR221 regulates TGF-β1-induced HSC activation through inhibiting autophagy by directly targeting LAMP2. Mol Med Rep 2021;24:777. [PMID: 34498712 DOI: 10.3892/mmr.2021.12417] [Reference Citation Analysis]
61 Gong X, Liu Y, Zheng C, Tian P, Peng M, Pan Y, Li X. Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma. Front Oncol 2022;12:827259. [PMID: 35186758 DOI: 10.3389/fonc.2022.827259] [Reference Citation Analysis]
62 Bardhi E, Mcdaniels J, Rousselle T, Maluf DG, Mas VR. Nucleic acid biomarkers to assess graft injury after liver transplantation. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100439] [Reference Citation Analysis]
63 Gallego-Durán R, Montero-Vallejo R, Maya-Miles D, Lucena A, Martin F, Ampuero J, Romero-Gómez M. Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases. Front Immunol 2021;12:667354. [PMID: 34899679 DOI: 10.3389/fimmu.2021.667354] [Reference Citation Analysis]
64 Zhang K, Xu X, Hu L. Sevoflurane attenuates hepatic ischemia reperfusion injury by the miR-122/Nrf2 pathway. Ann Transl Med 2022;10:350. [PMID: 35433991 DOI: 10.21037/atm-22-115] [Reference Citation Analysis]
65 Dong XC, Chowdhury K, Huang M, Kim HG. Signal Transduction and Molecular Regulation in Fatty Liver Disease. Antioxid Redox Signal 2021. [PMID: 33906425 DOI: 10.1089/ars.2021.0076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Shatoor AS, Al Humayed S, Almohiy HM. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2. J Physiol Biochem 2021. [PMID: 34651285 DOI: 10.1007/s13105-021-00850-9] [Reference Citation Analysis]
67 Tai Y, Zhao C, Lan T, Zhang L, Xiao Y, Tong H, Liu R, Tang C, Gao J. Integrated Analysis of Hepatic miRNA and mRNA Expression Profiles in the Spontaneous Reversal Process of Liver Fibrosis. Front Genet 2021;12:706341. [PMID: 34367261 DOI: 10.3389/fgene.2021.706341] [Reference Citation Analysis]
68 Ren R, He Y, Ding D, Cui A, Bao H, Ma J, Hou X, Li Y, Feng D, Li X, Liangpunsakul S, Gao B, Wang H. Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C/EBPα-miRNA-223 axis. Hepatology 2022;75:646-60. [PMID: 34510484 DOI: 10.1002/hep.32152] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Zhao Y, Xiang J, Cheng H, Liu X, Li F. Flexible photoelectrochemical biosensor for ultrasensitive microRNA detection based on concatenated multiplex signal amplification. Biosens Bioelectron 2021;194:113581. [PMID: 34461568 DOI: 10.1016/j.bios.2021.113581] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Li Y, Guo L, Hou Z, Gong H, Yan M, Zhang B. Role of MicroRNA-155 in Triptolide-induced hepatotoxicity via the Nrf2-Dependent pathway. J Ethnopharmacol 2021;281:114489. [PMID: 34363931 DOI: 10.1016/j.jep.2021.114489] [Reference Citation Analysis]
71 Zuo Z, Li Y, Zeng C, Xi Y, Tao H, Guo Y. Integrated Analyses Identify Key Molecules and Reveal the Potential Mechanism of miR-182-5p/FOXO1 Axis in Alcoholic Liver Disease. Front Med (Lausanne) 2021;8:767584. [PMID: 34950682 DOI: 10.3389/fmed.2021.767584] [Reference Citation Analysis]